Urogynecology and pelvic floor surgery 2026

Urogynecology and reconstructive pelvic floor surgery are in a phase of upheaval: the ban on transvaginal polypropylene mesh kits in many countries has fundamentally changed the surgical strategy and provided new impetus for native tissue repair techniques and minimally invasive approaches. At the same time, the AUA/SUFU Guideline 2024 has restructured the management of overactive bladder – moving away from rigid staged regimens towards patient-centered treatment choices. Robotic sacrocolpopexy is establishing itself as the standard for apical defects, and new findings on de novo stress incontinence after prolapse repair are influencing preoperative counseling.